- Home
- HQI vs RCEL Comparison
HQI vs RCEL Comparison
Compare HQI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- RCEL
- Stock Information
- Founded
- HQI 2002
- RCEL N/A
- Country
- HQI United States
- RCEL United States
- Employees
- HQI N/A
- RCEL N/A
- Industry
- HQI Professional Services
- RCEL Medical/Dental Instruments
- Sector
- HQI Consumer Discretionary
- RCEL Health Care
- Exchange
- HQI Nasdaq
- RCEL Nasdaq
- Market Cap
- HQI 143.3M
- RCEL 161.5M
- IPO Year
- HQI N/A
- RCEL N/A
- Fundamental
- Price
- HQI $10.06
- RCEL $5.19
- Analyst Decision
- HQI Strong Buy
- RCEL Strong Buy
- Analyst Count
- HQI 2
- RCEL 4
- Target Price
- HQI $16.00
- RCEL $16.50
- AVG Volume (30 Days)
- HQI 9.7K
- RCEL 293.0K
- Earning Date
- HQI 08-07-2025
- RCEL 08-07-2025
- Dividend Yield
- HQI 2.38%
- RCEL N/A
- EPS Growth
- HQI N/A
- RCEL N/A
- EPS
- HQI 0.24
- RCEL N/A
- Revenue
- HQI $33,651,000.00
- RCEL $71,661,000.00
- Revenue This Year
- HQI N/A
- RCEL $57.29
- Revenue Next Year
- HQI $4.99
- RCEL $28.07
- P/E Ratio
- HQI $38.65
- RCEL N/A
- Revenue Growth
- HQI N/A
- RCEL 41.35
- 52 Week Low
- HQI $9.04
- RCEL $5.10
- 52 Week High
- HQI $15.75
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- HQI 50.60
- RCEL 29.07
- Support Level
- HQI $9.71
- RCEL $5.10
- Resistance Level
- HQI $10.24
- RCEL $6.33
- Average True Range (ATR)
- HQI 0.27
- RCEL 0.32
- MACD
- HQI 0.05
- RCEL 0.02
- Stochastic Oscillator
- HQI 64.81
- RCEL 6.10
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.